Polymorphisms in the estrogen metabolism enzymes that detoxify catechol estrogens, namely, catechol-O-methyltransferase (COMT), glutathione (GSH), and quinone reductase are associated with PCa risk [167,168,169,170,171]. The gene discussed is COMT; the disease is posterior cortical atrophy.